Purpose Biochemical control is the main determinant of survival, clinical manifestations and
comorbidities in acromegaly. Transsphenoidal selective adenomectomy (TSA) is the initial …

Purpose The aim of this systematic review is to evaluate the long-term endocrine outcomes
and postoperative complications following endoscopic vs. microscopic transsphenoidal …

Objective Investigate the changes in the characteristics of presentation, in patients with
acromegaly over a period of approximately half a century. Methods The medical records of …

Simple Summary Pituitary neuroendocrine tumors (PitNET) are characterized to present a
heterogeneous behavior, and growth hormone (GH)-secreting PitNET is not an exception …

Purpose Acromegaly is a rare disease that often requires drug treatment to achieve control,
with pegvisomant being one of the most widely used therapies. In the present paper, we …

OBJECTIVE Acromegaly is a disease of acral enlargement and elevated serum levels of
insulin-like growth factor–1 (IGF-1) and growth hormone (GH), usually caused by a pituitary …

Objective To develop machine learning (ML) models that predict postoperative remission,
remission at last visit, and resistance to somatostatin receptor ligands (SRL) in patients with …

Objective A thorough follow-up study in which the same clinic presents the change in the
surgical outcomes of acromegaly over the years, is still lacking in the endoscopic era. In this …

Background The factors associated with initial and delayed remission after growth hormone
(GH)-secreting pituitary adenoma excision have not been completely elucidated. Methods …

Background: Although low-and middle-income countries (LMIC) bear the burden of the
pituitary adenomas, most research is conducted in developed countries. However, there has …